Asimov builds a CAD platform for biology, integrating engineered cells, genes, software, and lab-in-the-loop AI to make genetic design more predictable.
Products & media
A biologics expression system combining engineered CHO cells, genetic parts, design software, and development workflows for high-titer stable cell lines.
A lab-in-the-loop platform that uses design software, high-throughput experiments, and predictive models to optimize RNA therapeutic candidates.
A lentiviral-vector production system combining stable producer cell lines and software design tools for scalable cell-therapy manufacturing.
A modular gene-therapy toolkit for AAV payload design and stable, semi-stable, or transient vector production.
Team
Jobs
See all jobs for Asimov here.
Funding
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.
$175M$1.2B post-money valuation
$25M$135M post-money valuation
Led by
Horizons Ventures
$4.7M$15.7M post-money valuation